BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7728844)

  • 1. Activated clotting times in acute coronary syndromes and percutaneous transluminal coronary angioplasty.
    Wilson JM; Dougherty KG; Ellis KO; Ferguson JJ
    Cathet Cardiovasc Diagn; 1995 Jan; 34(1):1-5. PubMed ID: 7728844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adequate heparinization during PTCA: assessment using activated clotting times.
    Ogilby JD; Kopelman HA; Klein LW; Agarwal JB
    Cathet Cardiovasc Diagn; 1989 Dec; 18(4):206-9. PubMed ID: 2605621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris.
    Bertinchant JP; Polge A; Ledermann B; Genet L; Fabbro-Peray P; Raczka F; Brunet J; Poirey S; Wittenberg O; Pernel I; Nigond J
    Am J Cardiol; 1999 Jul; 84(1):51-7. PubMed ID: 10404851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Percutaneous transluminal coronary angioplasty in patients over 75 years old with acute myocardial infarct or unstable angina pectoris].
    Wojcik J; Chemnitius JM; Scholz KH; Ashmawy M; Kreuzer H; Tebbe U
    Med Klin (Munich); 1990 Jul; 85(7):409-14. PubMed ID: 2385205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombin III supplementation for patients undergoing PTCA for unstable angina pectoris. A controlled randomized double-blind pilot study.
    Grip L; Blombäck M; Egberg N; Olsson A; Svane B; Velander M
    Eur Heart J; 1997 Mar; 18(3):443-9. PubMed ID: 9076381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of tissue factor pathway inhibitor in the coronary circulation of patients with acute coronary syndromes.
    Golino P; Ravera A; Ragni M; Cirillo P; Piro O; Chiariello M
    Circulation; 2003 Dec; 108(23):2864-9. PubMed ID: 14656922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris.
    Hafner G; Rupprecht HJ; Luz M; Terres W; Schindel F; Friesen HJ; Heinrichs H; Jessel A; Meyer J; Prellwitz W
    Eur Heart J; 1996 Aug; 17(8):1207-15. PubMed ID: 8869862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of percutaneous transluminal coronary angioplasty in the treatment of unstable angina. Report from the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty and Coronary Artery Surgery Study Registries.
    Faxon DP; Detre KM; McCabe CH; Fisher L; Holmes DR; Cowley MJ; Bourassa MG; Van Raden M; Ryan TJ
    Am J Cardiol; 1984 Jun; 53(12):131C-135C. PubMed ID: 6233877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of recombinant hirudin (CGP 39 393) versus heparin in patients with stable angina undergoing coronary angioplasty.
    van den Bos AA; Deckers JW; Heyndrickx GR; Laarman GJ; Suryapranata H; Zijlstra F; Close P; Rijnierse JJ; Buller HR; Serruys PW
    Circulation; 1993 Nov; 88(5 Pt 1):2058-66. PubMed ID: 8222099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-, medium-, and long-term follow-up after percutaneous transluminal coronary angioplasty for stable and unstable angina pectoris.
    Kamp O; Beatt KJ; De Feyter PJ; van den Brand M; Suryapranata H; Luijten HE; Serruys PW
    Am Heart J; 1989 May; 117(5):991-6. PubMed ID: 2523638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The summary results of percutaneous transluminal coronary angioplasty at the Sveta Ekaterina State University Hospital in 1991-1994].
    Dzhorgova Iu; Petrov I; Atsev B; Nachev G; Chirkov A
    Khirurgiia (Sofiia); 1995; 48(1):51-8. PubMed ID: 7474760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Percutaneous transluminal coronary angioplasty (PTCA) in unstable angina pectoris: results and complications with reference to a new classification].
    Seggewiss H; Fassbender D; Gleichmann U; Mannebach H; Vogt J; Minami K
    Z Kardiol; 1991 Jul; 80(7):423-30. PubMed ID: 1926987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes of hemostasis, endogenous fibrinolysis, platelet activation and endothelins after percutaneous transluminal coronary angioplasty in patients with stable angina.
    Borries M; Heins M; Fischer Y; Stiegler H; Peters A; Reinauer H; Schoebel FC; Strauer BE; Leschke M
    J Am Coll Cardiol; 1999 Aug; 34(2):486-93. PubMed ID: 10440163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bivalirudin: a review of its potential place in the management of acute coronary syndromes.
    Carswell CI; Plosker GL
    Drugs; 2002; 62(5):841-70. PubMed ID: 11929334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Initial and mid-term results of coronary angioplasty in early post-infarction unstable angina].
    Metzger JP; Tabone X; le Feuvre C; Drobinski G; Piolot A; Bral M; le Pailleur C; Vacheron A
    Arch Mal Coeur Vaiss; 1990 Mar; 83(3):323-7. PubMed ID: 2108625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [One center's experience of coronary angioplasty with a 5 French catheter guide by a femoral approach at the same time as coronary angiography].
    Brasselet C; Metz D; Perotin S; Maillier B; Tassan-Mangina S; Deschildre A; Bonfils L; Jennessaux C; Blaise C; Elaerts J
    Arch Mal Coeur Vaiss; 2002 Apr; 95(4):269-74. PubMed ID: 12055765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence, outcome and prediction of early clinical events following percutaneous transluminal coronary angioplasty. A comparison between treatment with reviparin and unfractionated heparin/placebo (results of a substudy of the REDUCE trial).
    Preisack MB; Bonan R; Meisner C; Eschenfelder V; Karsch KR
    Eur Heart J; 1998 Aug; 19(8):1232-8. PubMed ID: 9740345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short and long term outcome of percutaneous transluminal coronary angioplasty in unstable versus stable angina pectoris: a report of the 1985-1986 NHLBI PTCA Registry.
    Bentivoglio LG; Holubkov R; Kelsey SF; Holmes DR; Sopko G; Cowley MJ; Myler RK
    Cathet Cardiovasc Diagn; 1991 Aug; 23(4):227-38. PubMed ID: 1889076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between abrupt vessel closure and the anticoagulant response to heparin or bivalirudin during coronary angioplasty.
    Bittl JA; Ahmed WH
    Am J Cardiol; 1998 Oct; 82(8B):50P-56P. PubMed ID: 9809892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Success and complication rates of coronary angioplasty in the unstable angina pectoris stage after myocardial infarct--a comparison with percutaneous transluminal coronary angioplasty in the acute infarct stage and unstable angina pectoris without preceding myocardial infarct].
    Haase KK; Mauser M; Voelker W; Ickrath O; Karsch KR
    Z Kardiol; 1989 Feb; 78(2):81-5. PubMed ID: 2524138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.